Published in Toxicol Ind Health on December 01, 1990
Statistical Comparison of Carcinogenic Effects and Dose-Response Relationships in Rats and Mice for 2,4-Toluene Diamine to those Ascribed to Toluene Diisocyanate. Hum Ecol Risk Assess (2012) 0.75
Re: Dieter, M.P., Boorman, G.A., Jameson, C.W., Matthews, H.B., and Huff, J.E. (1990). "The carcinogenic activity of commercial grade toluene diisocyanate in rats and mice in relation to the metabolism of the 2,4- and 2,6-TDI isomers." Toxicol. Ind. Health 6: 599-621. Toxicol Ind Health (1991) 0.75
Safety and efficacy assessment of standardized herbal formula PM012. BMC Complement Altern Med (2012) 0.75
Mobilization of lead from the skeleton during the postnatal period is larger than during pregnancy. J Lab Clin Med (1998) 3.18
Relationships of lead in breast milk to lead in blood, urine, and diet of the infant and mother. Environ Health Perspect (1998) 2.36
Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science (1985) 2.09
Pregnancy increases mobilization of lead from maternal skeleton. J Lab Clin Med (1997) 1.92
Use of historical control data in carcinogenicity studies in rodents. Toxicol Pathol (1984) 1.61
Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am J Pathol (1998) 1.52
High incidence of spontaneous urinary bladder and ureter tumors in the brown Norway rat. J Natl Cancer Inst (1974) 1.51
Toxicity and carcinogenicity of hydroquinone in F344/N rats and B6C3F1 mice. Food Chem Toxicol (1992) 1.48
Blood gene expression signatures predict exposure levels. Proc Natl Acad Sci U S A (2007) 1.48
Comparative results of 327 chemical carcinogenicity studies. Environ Health Perspect (1987) 1.39
Pharmacokinetics, interactions with macromolecules and species differences in metabolism of DEHP. Environ Health Perspect (1982) 1.39
An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Program. Environ Health Perspect (1990) 1.34
Species correlation in long-term carcinogenicity studies. Cancer Lett (1987) 1.33
Trichloroethylene. I. An overview. J Toxicol Environ Health (1977) 1.29
Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. J Natl Cancer Inst (1986) 1.26
Urolithiasis and bladder carcinogenicity of melamine in rodents. Toxicol Appl Pharmacol (1984) 1.24
Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat Res (1997) 1.23
Estrogen immunosuppression is regulated through estrogenic responses in the thymus. J Immunol (1984) 1.22
Carcinogenesis studies: results of 398 experiments on 104 chemicals from the U.S. National Toxicology Program. Ann N Y Acad Sci (1988) 1.20
Liver lesions in B6C3F1 mice: the National Toxicology Program, experience and position. Arch Toxicol Suppl (1987) 1.19
Comparison of site-specific and overall tumor incidence analyses for 81 recent National Toxicology Program carcinogenicity studies. Regul Toxicol Pharmacol (1986) 1.19
The metabolism and disposition of tris(1,3-dichloro-2-propyl) phosphate (Fyrol FR-2) in the rat. Toxicol Appl Pharmacol (1981) 1.19
National Toxicology Program nomenclature for hepatoproliferative lesions of rats. Toxicol Pathol (1986) 1.18
Toxicity of inhaled methyl isocyanate in F344/N rats and B6C3F1 mice. I. Acute exposure and recovery studies. Environ Health Perspect (1987) 1.18
A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat. Drug Metab Dispos (1977) 1.17
Results from 86 two-year carcinogenicity studies conducted by the National Toxicology Program. J Toxicol Environ Health (1984) 1.16
Two-hour methyl isocyanate inhalation exposure and 91-day recovery: a preliminary description of pathologic changes in F344 rats. Environ Health Perspect (1987) 1.16
Carcinogenicity testing of phthalate esters and related compounds by the National Toxicology Program and the National Cancer Institute. Environ Health Perspect (1982) 1.15
Concordance in diagnosis of mesotheliomas. Toxicol Pathol (1997) 1.14
The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. J Toxicol Environ Health (1983) 1.14
The effect of adult exposure to diethylstilbestrol in the mouse on macrophage function and numbers. J Reticuloendothel Soc (1980) 1.12
Neoplasms observed in untreated and corn oil gavage control groups of F344/N rats and (C57BL/6N X C3H/HeN)F1 (B6C3F1) mice. J Natl Cancer Inst (1985) 1.12
Inhalation toxicology and carcinogenicity of 1,3-butadiene in B6C3F1 mice following 65 weeks of exposure. Environ Health Perspect (1990) 1.11
Clinical toxicology of mercury. J Toxicol Environ Health (1977) 1.11
Pulmonary effects of prolonged ozone insult in rats. Morphometric evaluation of the central acinus. Lab Invest (1980) 1.10
Pharmacokinetics of PCBs. Annu Rev Pharmacol Toxicol (1984) 1.09
Chronic toxicity/oncogenicity evaluation of 60 Hz (power frequency) magnetic fields in B6C3F1 mice. Toxicol Pathol (1999) 1.09
The distribution and excretion of 2,4,5,2',5'-pentachlorobiphenyl in the rat. Drug Metab Dispos (1975) 1.09
Distribution and excretion of 2,2',4,4',5,5'-hexabromobiphenyl in rats and man: pharmacokinetic model predictions. Toxicol Appl Pharmacol (1980) 1.08
Feline brain abscesses due to Cladosporium trichoides. Sabouraudia (1977) 1.08
Examination of bone marrow, immunologic parameters and host susceptibility following pre- and postnatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Int J Immunopharmacol (1980) 1.08
Application of microencapsulation for toxicology studies. I. Principles and stabilization of trichloroethylene in gelatin-sorbitol microcapsules. Fundam Appl Toxicol (1987) 1.07
Dark adaptation and night vision. Fed Proc (1970) 1.07
The mouse bioassay for the detection of estrogenic activity in rodent diets: II. Comparative estrogenic activity of purified, certified and standard open and closed formula rodent diets. Lab Anim Sci (1987) 1.06
Metabolism of 4-chlorobiphenyl and 4,4'-dichlorobiphenyl in the rat: qualitative and quantitative aspects. J Agric Food Chem (1977) 1.06
Carcinogenesis studies design and experimental data interpretation/evaluation at the National Toxicology Program. Prog Clin Biol Res (1984) 1.05
Alternatives to using human experience in assessing health risks. Annu Rev Public Health (1987) 1.03
Rotenone, an anticarcinogen, inhibits cellular proliferation but not peroxisome proliferation in mouse liver. Cancer Lett (1995) 1.03
Dietary lead intakes for mother/child pairs and relevance to pharmacokinetic models. Environ Health Perspect (1997) 1.02
Transplantable calcitonin-secreting medullary carcinomas of the thyroid in the WAG-Rij rat. J Natl Cancer Inst (1974) 1.02
The mouse bioassay for the detection of estrogenic activity in rodent diets: I. A standardized method for conducting the mouse bioassay. Lab Anim Sci (1987) 1.02
Two-hour methyl isocyanate inhalation and 90-day recovery study in B6C3F1 mice. Environ Health Perspect (1987) 1.02
Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen:carcinogen pair--2,6- and 2,4-diaminotoluene. Toxicol Appl Pharmacol (1991) 1.01
Microsomal rat liver UDP glucuronyltransferase: effects of piperonyl butoxide and other factors on enzyme activity. Arch Biochem Biophys (1971) 0.99
Disposition and excretion of 2,3,7,8-tetrachlorodibenzofuran in the rat. Toxicol Appl Pharmacol (1980) 0.98
Classification of cystic keratinizing squamous lesions of the rat lung: report of a workshop. Toxicol Pathol (1997) 0.97
Naturally occurring medullary thyroid carcinoma in the rat. Arch Pathol (1972) 0.97
Allyl isothiocyanate: comparative disposition in rats and mice. Toxicol Appl Pharmacol (1984) 0.97
Identification of components in iodinated glycerol. J Pharm Sci (1989) 0.96
1,3-Butadiene induces cancer in experimental animals at all concentrations from 6.25 to 8000 parts per million. IARC Sci Publ (1993) 0.96
Long-term hazards of polychlorinated dibenzodioxins and polychlorinated dibenzofurans. Environ Health Perspect (1980) 0.96
Ultrastructural changes in the nasal mucosa of Fischer 344 rats and B6C3F1 mice following an acute exposure to methyl isocyanate. Environ Health Perspect (1987) 0.95
Immunological and biochemical responses in mice treated with mercuric chloride. Toxicol Appl Pharmacol (1983) 0.95
A review of the genetic toxicology of chlorinated dibenzo-p-dioxins. Mutat Res (1978) 0.95
Ovarian yolk sac carcinoma in mice. Vet Pathol (1986) 0.94
Comparison of the rates of exchange of lead in the blood of newly born infants and their mothers with lead from their current environment. J Lab Clin Med (1999) 0.94
The effect of age and exposure duration on cancer induction by a known carcinogen in rats, mice, and hamsters. Toxicol Appl Pharmacol (1983) 0.94
Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model. Drug Metab Dispos (1985) 0.94
Metabolism, disposition, and mutagenicity of 2,6-diaminotoluene, a mutagenic noncarcinogen. Drug Metab Dispos (1990) 0.93
Assessment of myelotoxicity caused by environmental chemicals. Environ Health Perspect (1982) 0.92
Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls. Toxicol Appl Pharmacol (1997) 0.92
Application of tumor, bacterial and parasite susceptibility assays to study immune alterations induced by environmental chemicals. Environ Health Perspect (1982) 0.92
The effect of adult exposure to diethylstilbestrol in the mouse: alterations in immunological functions. J Reticuloendothel Soc (1980) 0.92
Toxicology studies of a chemical mixture of 25 groundwater contaminants. II. Immunosuppression in B6C3F1 mice. Fundam Appl Toxicol (1989) 0.92
Blood lead-urine lead relationships in adults and children. Environ Res (1998) 0.91
Hexamita and Giardia as a cause of mortality in congenitally thymus-less (nude) mice. Clin Exp Immunol (1973) 0.91
Myelotoxicity and macrophage alteration in mice exposed to ochratoxin A. Toxicol Appl Pharmacol (1984) 0.91
Metabolism and disposition of diethylene glycol in rat and dog. Drug Metab Dispos (1992) 0.91
Metabolism and disposition of luminol in the rat. Xenobiotica (2000) 0.90
Proliferative lesions of the exocrine pancreas in male F344/N rats. Environ Health Perspect (1984) 0.90
Impact of diet on lead in blood and urine in female adults and relevance to mobilization of lead from bone stores. Environ Health Perspect (1999) 0.90
Relationship of hepatocarcinogenicity and hepatocellular proliferation induced by mutagenic noncarcinogens vs carcinogens. II. 1- vs 2-nitropropane. Toxicol Appl Pharmacol (1991) 0.90
Mechanisms of estrogen-induced myelotoxicity: evidence of thymic regulation. Int J Immunopharmacol (1984) 0.90
In vitro estrogenicity of the catechol metabolites of selected polychlorinated biphenyls. Toxicol Appl Pharmacol (1999) 0.90
Pharmacokinetics of halogenated hydrocarbons. Ann N Y Acad Sci (1979) 0.89
2,3,7,8-Tetrachlorodibenzofuran tissue distribution and excretion in guinea pig. Toxicol Appl Pharmacol (1981) 0.89
Carcinogenicity of p-chloroaniline in rats and mice. Food Chem Toxicol (1991) 0.89
Forestomach lesions in rats and mice administered 3-chloro-2-methylpropene by gavage for two years. Cancer Res (1986) 0.89
Value of historical control data and other issues related to the evaluation of long-term rodent carcinogenicity studies. Toxicol Pathol (1997) 0.88
Myelotoxicity induced in female B6C3F1 mice by inhalation of methyl isocyanate. Environ Health Perspect (1987) 0.88
Distribution and excretion of 2,4,5,2',4',5'-hexabromobiphenyl, the major component of Firemaster BP-6. J Toxicol Environ Health (1977) 0.88
The effect of adult exposure to diethylstilbestrol in the mouse: alterations in tumor susceptibility and host resistance parameters. J Reticuloendothel Soc (1980) 0.88
Effects of mononuclear cell leukemia on altered hepatocellular foci in Fischer 344 rats. Vet Pathol (1990) 0.88
Cell-mediated immunity and its application in toxicology. Environ Health Perspect (1982) 0.88
Metabolism, bioaccumulation, and incorporation of diethanolamine into phospholipids. Chem Res Toxicol (1995) 0.87